Surgical treatment of obesity

European Journal of Endocrinology

Volumn 158, Issue 2, 2008, Pages 135-145

  Bult, Mariëlle J F ^a   van Dalen, Thijs ^a   Muller, Alex F ^a  

^a DEPARTMENT OF SURGERY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; CALCIUM; CYANOCOBALAMIN; ENOXAPARIN; IRON; TETRAHYDROLIPSTATIN; THIAMINE; VITAMIN D; ANTIOBESITY AGENT; LIPID;

ANASTOMOSIS LEAKAGE; ARTIFICIAL VENTILATION; BARIATRIC SURGERY; BODY MASS; CARDIOVASCULAR RISK; CHOLECYSTECTOMY; CHOLELITHIASIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CYANOCOBALAMIN DEFICIENCY; DIABETES MELLITUS; DIET; EXERCISE; GASTRECTOMY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INTERNAL HERNIA; INTUBATION; IRON DEFICIENCY; LIFESTYLE MODIFICATION; LUNG EMBOLISM; MORTALITY; OBESITY; OVARY POLYCYSTIC DISEASE; PATIENT SELECTION; PHYSICAL ACTIVITY; POSTGASTRECTOMY SYNDROME; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEPSIS; SLEEP APNEA SYNDROME; STOMACH BYPASS; SURGICAL TECHNIQUE; THIAMINE DEFICIENCY; THROMBOSIS PREVENTION; TREATMENT FAILURE; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; VENOUS THROMBOEMBOLISM; VITAMIN D DEFICIENCY; VOMITING; WEIGHT REDUCTION; BILIARY TRACT SURGERY; BLOOD; CALORIC INTAKE; COMORBIDITY; EUROPE; GASTROPLASTY; HOSPITALIZATION; METHODOLOGY; MORBID OBESITY; RISK FACTOR; TREATMENT OUTCOME;

ANTI-OBESITY AGENTS; APPETITE DEPRESSANTS; BARIATRIC SURGERY; BILIARY TRACT SURGICAL PROCEDURES; BODY MASS INDEX; COMORBIDITY; DIABETES MELLITUS; ENERGY INTAKE; EUROPE; EXERCISE; GASTRIC BYPASS; GASTROPLASTY; HUMANS; LIPIDS; OBESITY, MORBID; OVERWEIGHT; PATIENT SELECTION; QUALITY OF LIFE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 38949196513     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0145     Document Type: Review

References (129)

1. James PT, Rigby N & Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. European Journal of Cardiovascular Prevention and Rehabilitation 2004 11 3-8.
2. York DA, Rössner S, Caterson I, Chen CM, James WP, Kumanyika S, Martorell R & Vorster HH. Prevention Conference VII: obesity, a worldwide epidemic related to heart disease and stroke: Group I: worldwide demographics of obesity. Circulation 2004 110 e463-e470.
3. Haslam DW & James WP. Obesity. Lancet 2005 366 1197-1209.
4. Meinders AE & Fogteloo J. Overweight and obesity; recommendations from the National Health Council. Nederlands Tijdschrift Voor Geneeskunde 2003 147 1847-1851.
5. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS & Koplan JP. The continuing epidemics of obesity and diabetes in the United States. Journal of the American Medical Association 2001 286 1195-1200.
6. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al MA & Bonneux L. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Annals of Internal Medicine 2003 138 24-32.
7. Raad voor de Volksgezondheid en Zorg. Gezondheid en gedrag. Zoetermeer, Raad voor de Volksgezondheid en Zorg, 2002.
8. Dixon JB, Pories WJ, O'Brien PE, Schauer PR & Zimmet P. Surgery as an effective early intervention for diabesity: why the reluctance? Diabetes Care 2005 28 472-474.
9. Santry HP, Gillen DL & Lauderdale DS. Trends in bariatric surgical procedures. Journal of the American Medical Association 2005 294 1909-1917.
10. Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith WD, Milas NC, Mattfeldt-Beman M, Belden L, Bragg C, Millstone M, Raczynski J, Brewer A, Singh B & Cohen J. Long-term weight loss and changes in blood pressure: results of the trials of hypertension prevention, phase II. Annals of Internal Medicine 2001 134 1-11.
11. Wood PD, Stefanick ML, Dreon DM, Frey-Hewitt B, Garay SC, Williams PT, Superko HR, Fortmann SP, Albers JJ & Vranizan KM. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. New England Journal of Medicine 1988 319 1173-1179.
12. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA & Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 2002 346 393-403.
13. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M & Wedel H. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. New England Journal of Medicine 2004 351 2683-2693.
14. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lonroth H, Naslund I, Olbers T, Stenlof K, Torgerson J, Agren G & Carlsson LM. Effects of bariatric surgery on mortality in Swedish obese subjects. New England Journal of Medicine 2007 357 741-752.
15. Sjostrom L, Larsson B, Backman L, Bengtsson C, Bouchard C, Dahlgren S, Hallgren P, Jonsson E, Karlsson J & Lapidus L. Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. International Journal of Obesity and Related Metabolic Disorders 1992 16 465-479.
16. Torgerson JS, Hauptman J, Boldrin MN & Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004 27 155-161.
17. Tsai AG & Wadden TA. Systematic review: an evaluation of major commercial weight loss programs in the United States. Annals of Internal Medicine 2005 142 56-66.
18. Li Z, Maglione M, Tu W, Mojica W. Arterburn D, Shugarman LR, Hilton L, Suttorp M, Solomon V, Shekelle PG & Morton SC. Meta-analysis: pharmacologic treatment of obesity. Annals of Internal Medicine 2005 142 532-546.
19. Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J & Rosenstock J. For the RIO-North America study group Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. Journal of the American Medical Association 2006 295 761-775.
20. Scheen AJ, Finer N, Hollander P, Jensen MD & Van Gaal LF. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomized controlled study. Lancet 2006 368 1660-1672.
21. Van Gaal LF, Rissanen AM, Scheen AJ, Acgler 0 & Rössner S. For the RIO-Europe study group. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005 365 1389-1397.
22. Yanovski SZ & Yanovski JA. Obesity. New England Journal of Medicine 2002 346 591-602.
23. Schneider BE & Mun EC. Surgical management of morbid obesity. Diabetes Care 2005 28 475-480.
24. Buchwald H. Consensus conference statement bariatric surgery for morbid obesity: health implications for patients, health professionals, and third party payers. Journal of the American College of Surgeons 2004 200 593-604.
25. Hess DS, Hess DW & Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obesity Surgery 2005 15 408-416.
26. Marceau P, Hould FS, Simard S, Lebel S, Bourque RA, Potvin M & Biron S. Biliopancreatic diversion with duodenal switch. World Journal of Surgery 1998 22 947-954.
27. Melissas J, Mouzas J, Filis D, Daskalakis M, Matrella E, Papadakis JA, Sevrisarianos N & Charalambides D. The intragastric balloon - smoothing the path to bariatric surgery. Obesity Surgery 2006 16 897-902.
28. Spyropoulos C, Katsakoulis E, Mead N, Vagenas K & Kalfarentzos F. Intragastric balloon for high-risk super-obese patients: a prospective analysis of efficacy. Surgery for Obesity and Related Diseases 2007 3 78-83.
29. Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, Nguyen NT, Li Z, Mojica WA, Hilton L, Rhodes S, Morton SC & Shekelle PG. Meta-analysis: surgical treatment of obesity. Annals of Internal Medicine 2005 142 547-559.
30. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K & Schoelles K. Bariatric surgery: a systematic review and meta-analysis. Journal of the American Medical Association 2004 292 1724-1737.
31. Sugerman HJ, Starkey JV & Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Annals of Surgery 1987 205 613-624.
32. Hall JC, Watts JM, O'Brien PE, Dunstan RE, Walsh JF, Slavotinek AH & Elmslie RG. Gastric surgery for morbid obesity. The Adelaide study. Annals of Surgery 1990 211 419-427.
33. Pories WJ, Flickinger EG, Meelheim D, van Rij AM & Thomas FT. The effectiveness of gastric bypass over gastric partition in morbid obesity: consequence of distal gastric and duodenal exclusion. Annals of Surgery 1982 196 389-399.
34. Naslund I, Wickbom G, Christoffersson E & Agren G. A prospective randomized comparison of gastric bypass and gastroplasty. Complications and early results. Acta Chirurgica Scandinavica 1986 152 681-689.
35. Howard L, Malone M, Michalek A, Carter J, Alger S & Van WJ. Gastric bypass and vertical banded gastroplasty - a prospective randomized comparison and 5-year follow-up. Obesity Surgery 1995 5 55-60.
36. Morino M, Toppino M, Bonnet G & Del GG. Laparoscopic adjustable silicone gastric banding versus vertical banded gastroplasty in morbidly obese patients: a prospective randomized-controlled clinical trial. Annals of Surgery 2003 238 835-841.
37. Scopinaro N, Gianetta E, Adami GF, Friedman D, Traverso E, Marinari GM, Cuneo S, Vitale B, Ballari F, Colombini M, Baschieri G & Bachi V. Biliopancreatic diversion for obesity at eighteen years. Surgery 1996 119 261-268.
38. Genco A, Bruni T, Doldi SB, Forestieri P, Marino M, Busetto L, Giardiello C, Angrisani L, Pecchioli L, Stornelli P, Puglisi F, Alkilani M, Nigri A, Di LN, Furbetta F, Cascardo A, Cipriano M, Lorenzo M & Basso N. Bioenterics intragastric balloon: the Italian experience with 2515 patients. Obesity Surgery 2005 15 1161-1164.
39. Mathus-Vliegen EM & Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointestinal Endoscopy 2005 61 19-27.
40. Pories WJ, Swanson MS, Macdonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G & Dolezal JM. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus Annals of Surgery 1995 222 339-350.
41. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L & Kelley D. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Annals of Surgery 2003 238 467-484.
42. Dixon JB & O'Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002 25 358-363.
43. Ballantyne GH, Farkas D, Laker S & Wasielewski A. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obesity Surgery 2006 16 1189-1197.
44. Dixon JB, Dixon AF & O'Brien PE. Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diabetic Medicine 2003 20 127-134.
45. Guidone C, Manco M, Valera-Mora E, Iaconelli A, Gniuli D, Mari A, Nanni G, Castagneto M, Calvani M & Mingrone G. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006 55 2025-2031.
46. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG & Alexandrides TK. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 2003 52 1098-1103.
47. Le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG & Bloom SR. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Annals of Surgery 2006 243 108-114.
48. Strader AD, Vahl TP, Jandacek RJ, Woods SC, D'Alessio DA & Seeley RJ. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. American Journal of Physiology. Endocrinology and Metabolism 2005 288 E447-E453.
49. Muscelli E, Mingrone G, Camastra S, Manco M, Pereira JA, Pareja JC & Ferrannini E. Differential effect of weight loss on insulin resistance in surgically treated obese patients. American Journal of Medicine 2005 118 51-57.
50. Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, Sancho J & San Millan JL. The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. Journal of Endocrinology and Metabolism 2005 90 6364-6369.
51. Karlsson J, Sjostrom L & Sullivan M. Swedish obese subjects (SOS) - an intervention study of obesity. Two-year follow-up of health-related quality of Me (HRQL) and eating behavior after gastric surgery for severe obesity. International Journal of Obesity and Related Metabolic Disorders 1998 22 113-126.
52. Schauer PR, Ikramuddin S, Gourash W. Ramanathan R & Luketich J. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Annals of Surgery 2000 232 515-529.
53. Dixon JB, Dixon ME & O'Brien PE. Quality of life after lap-band placement: influence of time, weight loss, and comorbidities. Obesity Research 2001 9 713-721.
54. MacDonald KG Jr, Long SD, Swanson MS, Brown RM, Morris P, Dohm GL & Pories WJ. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. Journal of Gastrointestinal Surgery 1997 1 213-220.
55. Sjostrom CD, Lissner L, Wedel H & Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS intervention study. Obesity Research 1999 7 477-484.
56. Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP & MacLean LD. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Annals of Surgery 2004 240 416-423.
57. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM & Hunt SC. Long-term mortality after gastric bypass surgery. New England Journal of Medicine 2007 357 753-761.
58. Flum DR, Salem L, Elrod JA, Dellinger EP, Cheadle A & Chan L. Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. Journal of the American Medical Association 2005 294 1903-1908.
59. Zingmond DS, McGory ML & Ko CY. Hospitalization before and after gastric bypass surgery. Journal of the American Medical Association 2005 294 1918-1924.
60. Nguyen NT, Silver M, Robinson M, Needleman B, Hartley G, Cooney R, Catalano R, Dostal J, Sama D, Blankenship J, Burg K, Stemmer E & Wilson SE. Result of a national audit of bariatric surgery performed at academic centers: a 2004 University Health System Consortium Benchmarking Project. Archives of Surgery 2006 141 445-449.
61. Nilsell K, Thorne A, Sjostedt S, Apelman J & Pettersson N. Prospective randomized comparison of adjustable gastric banding and vertical banded gastroplasty for morbid obesity. European Journal of Surgery 2001 167 504-509.
62. O'Brien PE, Dixon JB, Laurie C, Skinner S, Proietto J, McNeil J, Strauss B, Marks S, Schachter L, Chapman L & Anderson M. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Annals of Internal Medicine 2006 144 625-633.
63. Livingston EH, Huerta S, Arthur D, Lee S, De SS & Heber D. Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery. Annals of Surgery 2002 236 576-582.
64. McCullough PA, Gallagher MJ, deJong AT, Sandberg KR, Trivax JE, Alexander D, Kasturi G, Jafri SM, Krause KR, Chengelis DL, Moy J & Franklin BA. Cardiorespiratory fitness and short-term complications after bariatric surgery. Chest 2006 130 517-525.
65. Flum DR & Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. Journal of the American College of Surgeons 2004 199 543-551.
66. Melinek J, Livingston E, Cortina G & Fishbein MC. Autopsy findings following gastric bypass surgery for morbid obesity. Archives of Pathology and Laboratory Medicine 2002 126 1091-1095.
67. Pasulka PS, Bistrian BR, Benotti PN & Blackburn GL. The risks of surgery in obese patients. Annals of Internal Medicine 1986 104 540-546.
68. Fernandez AZ Jr, DeMaria EJ, Tichansky DS, Kellum JM, Wolfe LG, Meador J & Sugerman HJ. Experience with over 3000 open and laparoscopic bariatric procedures: multivariate analysis of factors related to leak and resultant mortality. Surgical Endoscopy 2004 18 193-197.
69. Lowe GD, Carter DC & Prentice CR. Preoperative prediction of postoperative deep-vein thrombosis. Lancet 1982 1 1474.
70. Pieracci FM, Barie PS & Pomp A. Critical care of the bariatric patient. Critical Care Medicine 2006 34 1796-1804.
71. Nguyen NT Goldman C, Rosenquist CJ, Arango A, Cole CJ, Lee SJ & Wolfe BM. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Annals of Surgery 2001 234 279-289.
72. Angrisani L, Furbetta F, Doldi SB, Basso N, Lucchese M, Giacomelli F, Zappa M, Di CL, Veneziani A, Turicchia GU, Alkilani M, Forestieri P, Lesti G, Puglisi F, Toppino M, Campanile E Capizzi FD, D'Atri C, Sciptoni L, Giardiello C, Di LN, Lacitignola S, Belvederesi N, Marzano B, Bernate P, Iuppa. A, Borrelli V & Lorenzo M. Lap band adjustable gastric banding system: the Italian experience with 1863 patients operated on 6 years. Surgical Endoscopy 2003 17 409-412.
73. Wu EC & Barba CA. Current practices in the prophylaxis of venous thromboembolism in bariatric surgery. Obesity Surgery 2000 10 7-13.
74. Scholten DJ, Hoedema RM & Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obesity Surgery 2002 12 19-24.
75. Mason EE, Renquist KE & Jiang D. Perioperative risks and safety of surgery for severe obesity. American Journal of Clinical Nutrition 1992 55 573S-576S.
76. Sapala JA, Wood MH, Schuhknecht MP & Sapala MA. Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obesity Surgery 2003 13 819-825.
77. Carmody BJ, Sugerman HJ, Kellum JM, Jamal MK, Johnson JM, Carbonell AM, Maher JW, Wolfe LG & DeMaria EJ. Pulmonary embolism complicating bariatric surgery: detailed analysis of a single institution's 24-year experience. Journal of the American College of Surgeons 2006 203 831-837.
78. Sugerman HJ, Sugerman EL, Wolfe L, KeIlum JM Jr, Schweitzer MA & DeMaria EJ. Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. Annals of Surgery 2001 234 41-46.
79. Nguyen NT, Ho HS, Palmer LS & Wolfe BM. A comparison study of laparoscopic versus open gastric bypass for morbid obesity. Journal of the American College of Surgeons 2000 191 149-155.
80. Wittgrove AC & Clark GW. Laparoscopic gastric bypass, Rouxen-Y-500 patients: technique and results, with 3-60 month follow-up. Obesity Surgery 2000 10 233-239.
81. Higa KD, Boone KB & Ho T. Complications of the laparoscopic Roux-en-Y gastric bypass: 1040 patients - what have we learned? Obesity Surgery 2000 10 509-513.
82. Livingston EH. Development of bariatric surgery-specific risk assessment tool. Surgery for Obesity and Related Diseases 2007 3 14-20.
83. Yeats M, Wedergren S, Fox N & Thompson JS. The use and modification of clinical pathways to achieve specific outcomes in bariatric surgery. American Surgeon 2005 71 152-154.
84. Podnos YD, Jimenez JC, Wilson SE, Stevens CM & Nguyen NT. Complications after laparoscopic gastric bypass: a review of 3464 cases. Archives of Surgery 2003 138 957-961.
85. Hamilton EC, Sims TL, Hamilton TT, Mullican MA, Jones DB & Provost DA. Clinical predictors of leak after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Surgical Endoscopy 2003 17 679-684.
86. Goldfeder LB, Ren CJ & Gill JR. Fatal complications of bariatric surgery. Obesity Surgery 2006 16 1050-1056.
87. Ganci-Cerrud G & Herrera ME. Role of radiologic contrast studies in the early postoperative period after bariatric surgery. Obesity Surgery 1999 9 532-534.
88. Rose DK, Cohen MM, Wigglesworth DF & DeBoer DP. Critical respiratory events in the postanesthesia. care unit. Patient, surgical, and anesthetic factors. Anesthesiology 1994 81 410-418.
89. Fujioka K. Follow-up of nutritional and metabolic problems after bariatric surgery. Diabetes Care 2005 28 481-484.
90. Nguyen NT, Stevens CM & Wolfe BM. Incidence and outcome of anastomotic stricture after laparoscopic gastric bypass. Journal of Gastrointestinal Surgery 2003 7 997-1003.
91. Balsiger BM, Poggio JL, Mai J, Kelly KA & Sarr MG. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. Journal of Gastrointestinal Surgery 2000 4 598-605.
92. Nightengale ML, Sarr MG, Kelly KA, Jensen MD, Zinsmeister AR & Palumbo PJ. Prospective evaluation of vertical banded gastroplasty as the primary operation for morbid obesity. Mayo Clinic Proceedings 1991 66 773-782.
93. Balsiger BM, Murr MM, Mai J & Sarr MG. Gastroesophageal reflux after intact vertical banded gastroplasty: correction by conversion to Roux-en-Y gastric bypass. Journal of Gastrointestinal Surgery 2000 4 276-281.
94. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML & Lloyd RV. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. New England Journal of Medicine 2005 353 249-254,
95. DeMaria EJ, Sugerman HJ, Meador JG, Doty JM, Kellum JM, Wolfe L, Szucs RA & Turner MA. High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity. Annals of Surgery 2001 233 809-818.
96. DeMaria EJ. Laparoscopic adjustable silicone gastric banding: complications. Journal of Laparoendoscopic and Advanced Surgical Techniques 2003 13 271-277.
97. O'Brien PE & Dixon JB. Lap-band: outcomes and results. Journal of Laparoendoscopic and Advanced Surgical Techniques 2003 13 265-270.
98. Ren CJ, Horgan S & Ponce J. US experience with the LAP-BAND system. American Journal of Surgery 2002 184 46S-50S.
99. Halverson JD. Micronutrient deficiencies after gastric bypass for morbid obesity. American Surgeon 1986 52 594-598.
100. Amaral JF, Thompson WR, Caldwell MD, Martin HF & Randall HT. Prospective hematologic evaluation of gastric exclusion surgery for morbid obesity. Annals of Surgery 1985 201 186-193.
101. Avinoah E, Ovnat A & Charuzi I. Nutritional status seven years after Roux-en-Y gastric bypass surgery. Surgery 1992 111 137-142.
102. Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR & Greenspan SL. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. Journal of Endocrinology and Metabolism 2004 89 1061-1065.
103. Dibble JB, Sheridan P & Losowsky MS. A survey of vitamin D deficiency in gastrointestinal and liver disorders. Quarterly Journal of Medicine 1984 53 119-134.
104. Johnson JM, Maher JW DeMaria EJ, Downs RW, Wolfe LG & Kellum JM. The long-term effects of gastric bypass on vitamin D metabolism. Annals of Surgery 2006 243 701-704.
105. Collazo-Clavell ML, Jimenez A, Hodgson SF & Sarr MG. Osteomalacia after Roux-en-Y gastric bypass. Endocrine Practice 2004 10 195-198.
106. Fujioka K. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options. Obesity Research 2002 10 (Suppl 2) 116S-123S.
107. Goode LR, Brolin RE, Chowdhury HA & Shapses SA. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obesity Research 2004 12 40-47.
108. Chapin BL, LeMar HJ Jr, Knodel DH & Carter PL. Secondary hyperparathyroidism following biliopancreatic diversion. Archives of Surgery 1996 131 1048-1052.
109. Marceau P, Biron S, Lebel S, Marceau S, Hould FS, Simard S, Dumont M & Fitzpatrick LA. Does bone change after biliopancreatic. diversion? Journal of Gastrointestinal Surgery 2002 6 690-698.
110. Newbury L, Dolan K, Hatzifotis M, Low N & Fielding G. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obesity Surgery 2003 13 893-895.
111. Weinsier RL, Wilson LJ & Lee J. Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone - formation. American Journal of Medicine 1995 98 115-117.
112. Villegas L, Schneider B, Provost D, Chang C, Scott D, Sims T, Hill L, Hynan L & Jones D. Is routine cholecystectomy required during laparoscopic gastric bypass? Obesity Surgery 2004 14 206-211.
113. Wudel LJ Jr, Wright JK, Debelak JP, Allos TM, Shyr Y & Chapman WC. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. Journal of Surgical Research 2002 102 50-56.
114. O'Brien PE & Dixon JB. A rational approach to cholelithiasis in bariatric surgery: its application to the laparoscopically placed adjustable gastric band. Archives of Surgery 2003 138 908-912.
115. Inge TH, Xanthakos SA & Zeller MR. Bariatric surgery for pediatric extreme obesity: now or later? International Journal of Obesity 2007 31 1-14.
116. Nadler EP, Youn HA, Ginsburg HB, Ren CJ & Fielding GA. Shortterm results in 53 US obese pediatric patients treated with laparoscopic adjustable gastric banding. Journal of Pediatric Surgery 2007 42 137-141.
117. Wadden TA & Tsai AG. Bariatric surgery: crossing a body mass index threshold. Annals of Internal Medicine 2006 144 689-691.
118. Schumann R, Jones SB, Ortiz VE, Connor K, Pulai I, Ozawa ET, Harvey AM & Carr DB. Best practice recommendations for anesthetic Perioperative care and pain management in weight loss surgery. Obesity Research 2005 13 254-266.
119. Benumof JL. Obstructive sleep apnea in the adult obese patient: implications for airway management. Journal of Clinical Anesthesia 2001 13 144-156.
120. Benumof JL. Obesity, sleep apnea, the airway and anesthesia. Current Opinion in Anaesthesiology 2004 17 21-30.
121. Ramaswamy A, Gonzalez R & Smith CD. Extensive preoperative testing is not necessary in morbidly obese patients undergoing gastric bypass. Journal of Gastrointestinal Surgery 2004 8 159-164.
122. Murphy KG & Bloom SR. Gut hormones and the regulation of energy homeostasis. Nature 2006 444 854-859.
123. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP & Purnell JQ. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New England Journal of Medicine 2002 346 1623-1630.
124. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, Castagneto M & Marescaux J. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Annals of Surgery 2006 244 741-749.
125. Ballantyne GH, Gumbs A & Modlin IM. Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokinese, leptin, adiponectin and resistin. Obesity Surgery 2005 15 692-699.
126. Ballantyne GH. Peptide YY(1-36) and peptide YY(3-36). Part II. Changes after gastrointestinal surgery and bariatric surgery. Obesity Surgery 2006 16 795-803.
127. Cummings DE. Gastric bypass and nesidioblastosis - too much of a good thing for islets? New England Journal of Medicine 2005 353 300-302.
128. Kotidis EV, Koliakos GG, Baltzopoulos VG, Ioannidis KN, Yovos JG & Papavramidis ST. Serum ghrelin, teptin and adiponectin levels before and after weight loss: comparison of three methods of treatment - a prospective study. Obesity Surgery 2006 16 1425-1432.
129. Mun EC, Blackburn GL & Matthews JB. Current status of medical and surgical therapy for obesity. Gastroenterology 2001 120 669-681.